🟢 Aspire BioPharma is trading 8.7% up in after-hours trading; no company-specific catalyst identified

Aspire BioPharma is trading 8.71% up at $8.11 in after-hours trading after closing at $7.46 on November 2; the cause of the rise remains unclear.

• No company-specific announcement explaining the move was identified, and the company-news listing showed no headlines for November 2.
• Healthcare stocks were reported lower late Monday, while supplied major-index figures were mixed; available evidence does not establish a sector or broad-market catalyst.